Literature DB >> 21044010

Cancer stem cells and the tumor microenvironment: soloists or choral singers.

A Albini1, E Cesana, D M Noonan.   

Abstract

The idea of cancer stem cell (CSC) has recently moved to the forefront of cancer research. There is still a lack of a widespread consensus on their description and definition. ,The increasing literature on CSCs has compelled researchers worldwide to rewrite the natural history of cancer including those cells as principal players as well as to revise their views on tumor formation and progression. CSCs are tumor cell components that can initiate a new tumor after an apparent therapeutic eradication. A functional definition of cancer stem cell or cancer initiating cell is that of a cell which, when transplanted in a mouse model, can give rise to a tumor recapitulating the original one or even a phenotypically diverse tumor related to the tumor of origin. Since the characteristic asymmetric division of stem cells is somewhat anomalous in cancer, it might be advisable to refer to them as "stemloids". Stemness in cancer is not as much as an identity but rather a status. There is increasing evidence of the importance of the tumor and the host micro-environment in conditioning the stem cell status itself. The cancer stem cell micro-environment may be the key in the development of therapeutic strategies. We must think in terms of targeting "standard" tumor cells, cancer stem cells, and also their niche and tumor micro-environment. Here we discuss some features of cancer stem cells, and the role of the micro-environment, envisaging a choral view of cancer stem cell development and-or latency, towards development of specific therapeutic approaches. Here we propose models of replication and quiescence and the modulation by cells, genes and miRNAs. We also summarize in a table surface makers useful for the identification and isolation of CSCs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21044010     DOI: 10.2174/138920111794295756

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  9 in total

Review 1.  Role of nuclear receptors in breast cancer stem cells.

Authors:  Alessio Papi; Marina Orlandi
Journal:  World J Stem Cells       Date:  2016-03-26       Impact factor: 5.326

Review 2.  Cancer prevention by targeting angiogenesis.

Authors:  Adriana Albini; Francesca Tosetti; Vincent W Li; Douglas M Noonan; William W Li
Journal:  Nat Rev Clin Oncol       Date:  2012-07-31       Impact factor: 66.675

Review 3.  A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis.

Authors:  Antonino Bruno; Guido Ferlazzo; Adriana Albini; Douglas M Noonan
Journal:  J Natl Cancer Inst       Date:  2014-09-01       Impact factor: 13.506

4.  ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature.

Authors:  Lynn Roy; Serene J Samyesudhas; Martin Carrasco; Jun Li; Stancy Joseph; Richard Dahl; Karen D Cowden Dahl
Journal:  Oncotarget       Date:  2014-09-30

Review 5.  Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma.

Authors:  Juan Pedro Martinez-Barbera
Journal:  Neuropathol Appl Neurobiol       Date:  2015-04-23       Impact factor: 8.090

Review 6.  Orchestration of angiogenesis by immune cells.

Authors:  Antonino Bruno; Arianna Pagani; Laura Pulze; Adriana Albini; Katiuscia Dallaglio; Douglas M Noonan; Lorenzo Mortara
Journal:  Front Oncol       Date:  2014-07-02       Impact factor: 6.244

7.  Strategies to Prevent "Bad Luck" in Cancer.

Authors:  Adriana Albini; Silvio Cavuto; Giovanni Apolone; Douglas M Noonan
Journal:  J Natl Cancer Inst       Date:  2015-08-04       Impact factor: 13.506

8.  Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.

Authors:  Barbara Bassani; Desirèe Bartolini; Arianna Pagani; Elisa Principi; Massimo Zollo; Douglas M Noonan; Adriana Albini; Antonino Bruno
Journal:  PLoS One       Date:  2016-07-01       Impact factor: 3.240

9.  Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.

Authors:  Constanze Buhrmann; Mina Yazdi; Bastian Popper; Parviz Shayan; Ajay Goel; Bharat B Aggarwal; Mehdi Shakibaei
Journal:  Nutrients       Date:  2018-07-12       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.